A detailed history of Morgan Dempsey Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Morgan Dempsey Capital Management LLC holds 111 shares of LLY stock, worth $83,029. This represents 0.03% of its overall portfolio holdings.

Number of Shares
111
Previous 23 382.61%
Holding current value
$83,029
Previous $20,000 390.0%
% of portfolio
0.03%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $67,948 - $84,481
88 Added 382.61%
111 $98,000
Q3 2022

Oct 18, 2022

BUY
$296.48 - $337.87 $6,819 - $7,771
23 New
23 $7,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Morgan Dempsey Capital Management LLC Portfolio

Follow Morgan Dempsey Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Dempsey Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Dempsey Capital Management LLC with notifications on news.